Long-term activity of clopidogrel: A three-month appraisal in healthy volunteers

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue SUPPL. 2, 1999, Pages 21-23

  Caplain, Henri ^a   Cariou, Roger ^b  

^a Hopital de la Fondation Cognacq Jay   (France)

^b SANOFI   (France)

Author keywords

Bleeding time; Clopidogrel; Long term effect; Platelet aggregation; Repeated dosing

Indexed keywords

CLOPIDOGREL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLEEDING TIME; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS;

EID: 0032810436     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Thebault JJ, Kieffer G, Lowe GDO, Nimmo WS, Cariou R. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost 1999;25(Suppl 2):9-14
2. Boneu B. Clopidogrel dose-ranging phase II study in subjects with atherosclerotic disease. J Am Coll Cardiol 1996;27 2 (suppl A):132A-133A
3. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67P-68P
4. Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous "venostasis" bleeding time technique. J Lab Clin Med 1941;26:1812-1822
5. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in subjects at risk of ischaemic events (CAPRIE). Lancet 1996;9058:1329-1339